Showing results (261-270 of 769) with videos related to

Sort By:
Pageof 77
Archives of Neurology|April 13, 2005
Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosisJ Sastre-Garriga, G T Ingle, D T Chard, et al.
Neurology|June 1, 1997
Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imagingG Giovannoni, M Lai, J Thorpe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 24, 1999
Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?C A Davie, N C Silver, G J Barker, et al.
Brain : a Journal of Neurology|April 29, 1998
Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical featuresN Tubridy, A J Coles, P Molyneux, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1995
Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adultsB N Harding, N Alsanjari, S J Smith, et al.
Magnetic Resonance in Medicine|June 23, 2006
In vivo diffusion tensor imaging of the human optic nerve: pilot study in normal controlsC A M Wheeler-Kingshott, S A Trip, M R Symms, et al.
Functional Neurology|October 16, 2013
Development of a high-resolution fat and CSF-suppressed optic nerve DTI protocol at 3T: application in multiple sclerosisR S Samson, M Kolappan, D L Thomas, et al.
Neuroimage|August 2, 2012
Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: a pilot study with application to magnetisation transfer measurementsM C Yiannakas, H Kearney, R S Samson, et al.
Brain : a Journal of Neurology|August 1, 1988
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosisD H Miller, P Rudge, G Johnson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter studyP D Molyneux, P A Brex, C Fogg, et al.
Pageof 77